Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic disease
Authors:
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 66 (2) , 113-120
Abstract
Objective. The percentage measurement of hypochromic red cells (HYPO) and reticulocyte haemoglobin content (CHr) using the ADVIA system has recently been validated as a useful tool in indicating iron deficiency, also in cases of chronic diseases such as renal failure. The aim of this study was to evaluate the extent to which the red cell parameters, RBC‐Y and RET‐Y, provided by Sysmex XE 2100, correlate with HYPO and CHr. Material and methods. The laboratory markers of iron status were evaluated together with HYPO, CHr, RBC‐Y and RET‐Y in 92 healthy subjects (C), 42 iron‐deficient patients (ID) and 88 uraemic patients receiving regular dialysis treatment (RDT). Results. In ID patients, increased HYPO and decreased RBC‐Y, CHr and RET‐Y values, with no overlapping with reference values, were found and a significant correlation was present between ADVIA 120 and Sysmex indices (ppConclusions. This study confirmed the validity of RBC‐Y in the management of ID, but not in RDT, where the diagnostic power of RBC‐Y as an index of cell hypochromia is limited owing to high MCV values.Keywords
This publication has 23 references indexed in Scilit:
- Potential Utility of Ret-Y in the Diagnosis of Iron-Restricted ErythropoiesisClinical Chemistry, 2004
- The New Reticulocyte Parameter (RET-Y) of the Sysmex XE 2100American Journal of Clinical Pathology, 2004
- Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin contentClinical and Experimental Nephrology, 2003
- Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiencyBlood, 2002
- A randomized trial of iron deficiency testing strategies in hemodialysis patients11See Editorial by Besarab, p. 2412.Kidney International, 2001
- Reticulocyte Parameters as Potential Discriminators of Recombinant Human Erythropoietin Abuse in Elite AthletesInternational Journal of Sports Medicine, 2000
- Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysisNephrology Dialysis Transplantation, 1999
- Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patientsNephrology Dialysis Transplantation, 1997
- The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapyJournal of Perinatal Medicine, 1995
- Detection of functional iron deficiency during erythropoietin treatment: a new approach.BMJ, 1992